| 0 | ℹ |
Switch to injectable cabotegravir-rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial.
(linkinghub.elsevier.com)
|
The Lancet 2026-09-17 | #hiv #clinical trial #adolescent #adherence | |
| 0 | ℹ |
N4BP1 uses tandem KH domains to associate with EDC4 and mRNA decapping factors in P-bodies.
(nature.com)
|
Communications Biology 2026-09-17 | #rna decay #p-bodies #protein-protein interaction #hiv #structural biology | |
| 0 | ℹ |
Health Economic Analysis of the AMBITION Protocol for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis in the United States.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-09-17 | #hiv #meningitis #antifungal #cryptococcus |